FB plans campaign in India to fight COVID related misinformation : Bulletin: Business Today
Business Today

FB plans campaign in India to fight COVID related misinformation

Loading the player...

Rashi Bisaria | May 14, 2021

Facebook plans campaign in India to fight COVID-19 related misinformation

Facebook on Thursday said it will roll out a new campaign in India in the coming weeks to "educate and inform people" about how to detect misinformation related to Covid-19, and encourage users to check the information they receive against an authentic source. The social networking giant has removed over 12 million pieces of "harmful" misinformation on Covid-19 globally from Instagram and its own platform during the pandemic, including falsehoods about approved vaccines.

COVID-19 crisis: Indian, South African variants detected in Americas, says WHO expert

The newest variant, the Indian B.1.617 variant, has been detected in cases in eight countries of the Americas, including Canada and the United States. The four most worrying coronavirus variants have been detected in virtually all countries and territories of the Americas, but although they are more transmissible there is no evidence they are more lethal, a World Health Organization expert said on Thursday.

COVID-19 surge: Centre says virus may re-emerge, calls for preparations

As the country battles the second wave of COVID-19, the government Thursday said the virus may emerge again and so preparations have to be made at the national level in collaboration with states, infrastructure needs to be ramped up while curbs and appropriate behaviour must be followed. Dismissing allegations that the government was unaware of the intensity of the second wave, NITI Aayog member (health) Dr V K Paul said, "We kept warning again and again from this platform that the second wave of COVID-19 will come.

Bharat Biotech agrees to open Covaxin manufacturing to others

Bharat Biotech has agreed to allow other companies to manufacture its coronavirus vaccine Covaxin, informed NITI Aayog Member (Health) Dr VK Paul. Addressing a press conference on the status of COVID-19 situation in the country on Thursday, Paul invited companies interested in joining the initiative to expand the production of Covaxin.

Alibaba reports first-ever operating loss in 7 years due to anti-monopoly fine

China's top e-commerce platform Alibaba Group Holding Ltd on May 13 posted its first quarterly operating loss since going public in 2014 due to a record anti-monopoly fine by the country's market regulator. Its US-listed shares fell nearly 3 percent in choppy trading, even as the company forecast strong 2022 revenue, betting that the pandemic-driven shift to online shopping will remain resilient.

Not a coverup, reasonable for India to increase vaccine dose gap when there's shortage: Dr Fauci

Top US health expert Dr Anthony Fauci has said that it is reasonable to increase the gap between two doses of vaccines when there's a shortage while referring to India increasing the time between two doses of Covishield. "When you don't have enough vaccines, extending duration between the first and second dose to get more people to at least get the first dose is a reasonable approach. It is unlikely that long delay would have a negative effect on vaccine efficacy," said Dr Anthony Fauci.

More from this section